GF
Gabelli Funds Portfolio holdings
AUM
$14.1B
1-Year Return
24.08%
This Quarter Return
+14.9%
1 Year Return
+24.08%
3 Year Return
+81.74%
5 Year Return
+169.49%
10 Year Return
+407.67%
AUM
$15.9B
AUM Growth
+$1.31B
(+9%)
Cap. Flow
-$498M
Cap. Flow
% of AUM
-3.13%
Top 10 Holdings %
Top 10 Hldgs %
9.92%
Holding
1,237
New
85
Increased
202
Reduced
410
Closed
96
Top Buys
| 1 |
ARRS
ARRIS International plc Ordinary Shares
ARRS
|
+$72.5M |
| 2 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
+$67.4M |
| 3 |
B
Barrick Mining Corporation
B
|
+$66.5M |
| 4 |
ELLI
Ellie Mae Inc
ELLI
|
+$64.6M |
| 5 |
IDTI
Integrated Device Technology I
IDTI
|
+$60.1M |
Top Sells
| 1 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$134M |
| 2 |
TFCF
Twenty-First Century Fox, Inc. Class B
TFCF
|
+$109M |
| 3 |
VVC
Vectren Corporation
VVC
|
+$84.4M |
| 4 |
NAV
Navistar International
NAV
|
+$72.7M |
| 5 |
GOLD
Randgold Resources Ltd
GOLD
|
+$69.4M |
Sector Composition
| 1 | Industrials | 17.01% |
| 2 | Communication Services | 13.57% |
| 3 | Utilities | 11.34% |
| 4 | Financials | 9.1% |
| 5 | Consumer Discretionary | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Amgen
AMGN
$150B
| $11.9M | 0.07% |
62,500
| – | – |
|
327
Bio-Rad Laboratories Class A
BIO
$7.49B
| $11.8M | 0.07% |
38,600
+15,400
| +66% | +$4.71M |
|
328
Atmos Energy
ATO
$26.3B
| $11.8M | 0.07% |
114,200
| – | – |
|
|
TEN
329
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $11.7M | 0.07% |
529,900
-64,900
| -11% | -$1.44M |
|
330
D.R. Horton
DHI
$52.5B
| $11.6M | 0.07% |
280,000
| – | – |
|
331
Timken Company
TKR
$5.32B
| $11.5M | 0.07% |
264,000
| – | – |
|
332
Evolent Health
EVH
$1.07B
| $11.4M | 0.07% |
908,500
+195,000
| +27% | +$2.45M |
|
|
CUTR
333
DELISTED
Cutera, Inc.
CUTR
| $11.4M | 0.07% |
644,807
+34,400
| +6% | +$607K |
|
334
CMS Energy
CMS
$21.3B
| $11.4M | 0.07% |
205,000
| – | – |
|
335
Spire
SR
$4.5B
| $11.4M | 0.07% |
138,000
| – | – |
|
336
NiSource
NI
$19.2B
| $11.3M | 0.07% |
393,000
| – | – |
|
|
PRMW
337
DELISTED
Primo Water Corporation
PRMW
| $11.2M | 0.07% |
768,000
| – | – |
|
|
PVG
338
DELISTED
PRETIUM RESOURCES INC.
PVG
| $11.1M | 0.07% |
+1,295,000
| New | +$11.1M |
|
339
Boston Scientific
BSX
$156B
| $11M | 0.07% |
287,000
-49,400
| -15% | -$1.9M |
|
|
OSIR
340
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
| $11M | 0.07% |
578,517
-15,155
| -3% | -$288K |
|
341
Ingredion
INGR
$8.08B
| $11M | 0.07% |
116,000
-15,000
| -11% | -$1.42M |
|
342
Cohen & Steers
CNS
$3.63B
| $10.9M | 0.07% |
258,200
-2,000
| -0.8% | -$84.5K |
|
343
Kennametal
KMT
$1.59B
| $10.9M | 0.07% |
296,000
+500
| +0.2% | +$18.4K |
|
344
Equinor
EQNR
$62.9B
| $10.9M | 0.07% |
495,000
| – | – |
|
345
Eli Lilly
LLY
$676B
| $10.8M | 0.07% |
83,398
-63,702
| -43% | -$8.27M |
|
|
SJR
346
DELISTED
Shaw Communications Inc.
SJR
| $10.8M | 0.07% |
518,000
| – | – |
|
347
Medtronic
MDT
$118B
| $10.7M | 0.07% |
117,900
+5,200
| +5% | +$474K |
|
348
Nexstar Media Group
NXST
$5.98B
| $10.6M | 0.07% |
98,000
-7,000
| -7% | -$759K |
|
349
Chesapeake Utilities
CPK
$2.91B
| $10.6M | 0.07% |
116,300
| – | – |
|
350
Novartis
NVS
$245B
| $10.5M | 0.07% |
121,644
-22,320
| -16% | -$1.92M |
|